Courtagen Gene Panel Analysis Refines Risky Genes in Neurodevelopmental Disorder Cases Marked by Epilepsy Investigators used gene panel sequence data to look at rare de novo variant frequencies in potential risk genes for neurodevelopmental disorders with epilepsy. Cannabis Testing Labs Adopt Molecular Methods as Throughput, Sample Diversity Skyrocket Premium The number of US states legalizing cannabis for medical and recreational use is growing, expanding the market for pathogen detection solutions. Courtagen Closes Genetic Testing Business, Citing Regulatory, Reimbursement Challenges Going forward, the company will focus on its wholly owned subsidiary Medicinal Genomics Corporation, which conducts cannabis genetics research. Medicinal Genomics, Courtagen Receive NIDA Grant to Detect Toxins in Cannabis The SBIR Phase 1 award will go toward developing a test using immuno-PCR technology to detect toxins in medical marijuana. Courtagen Life Sciences, Certainty Health Collaborate on Neurological Disorders The two firms are collaborating on a system to share genotypic, phenotypic, and treatment outcomes data with physicians on a mobile-device network. Sep 16, 2016 Courtagen, Astellas Partner on Mitochondrial Disease Drug Development Jan 21, 2016 Courtagen Receives Clinical Laboratory Approval in New York State Jul 15, 2015 Courtagen Raises $20M Jun 17, 2015 Courtagen Raises $7.5M Apr 23, 2015 Courtagen Inks Distribution Deals for Israel, Thailand Jun 25, 2014 Bioinn to Distribute Courtagen's NGS Tests in Taiwan Jun 20, 2014 Courtagen Raises $6.3M May 29, 2014 Courtagen Inks NGS Test Distribution Agreement with Sciencewerke May 15, 2014 Q&A: Courtagen's Kevin McKernan on Skirting Sequencing Gene Patents With Novel PCR Methods Premium Apr 23, 2014 Courtagen and Connecticut Children's Medical Center Partner to ID Autism Genes Apr 10, 2014 Courtagen, SimulConsult Ink Deal for Clinical Interpretation of Genetic Tests Mar 25, 2014 Courtagen to Provide Genetic Profiling for Raptor's Mitochondrial Disorder Drug Trial Jul 3, 2013 Experts Discuss Benefits and Risks of Panels, Exomes, Whole Genomes for Diagnostics Premium Nov 15, 2012 Courtagen Inks Emerging Markets Deal with Alliance Global Group Nov 1, 2012 New Products: Courtagen's EpiSeek Test Premium Jul 20, 2012 Sandia Looks to Out-License New Point-of-Care Multiplex Immunoassay Platform Premium Jul 11, 2012 New Products: Courtagen's NucSeekPDx Premium Jul 3, 2012 Scienion Places Arrayers with Procognia, Courtagen for Chip Production Premium Jun 25, 2012 Courtagen, Scienion Ink Protein Biochip Deal Jun 19, 2012 Courtagen's Mitochondrial DNA Sequencing Projects Could Lead to New Protein Array Tests Premium Load More Breaking News Long COVID Clues Found in Acute SARS-CoV-2 Infection Blood Samples People in the News at Roche, Mammoth Biosciences, NeoGenomics, Molecular Assemblies, More New Products Posted to GenomeWeb: Thermo Fisher, Element Biosciences, Dante Genomics, More Tesis Biosciences to Develop miRNA Biomarkers for mTBI Diagnosis In Brief This Week: Danaher, Lucira Health, Novacyt, Molecular Devices The Scan Cell Atlas of Human Lung Development Gives View of Developing Airway Researchers have generated a cell atlas of human lung development, which they report in Cell. Study Finds Costs of Genome Sequencing May Limit Utility in Routine Care Researchers report in the European Journal of Human Genetics that genome sequencing for rare disease diagnoses currently has similar benefits as less expensive exome analysis. Study Suggests Nursing Mother's Diet Can Impact Offspring's Gut Microbiome A new Cell Host and Microbe paper finds that mice whose mothers were fed a low-fiber diet during nursing experience lasting microbiota dysbiosis and increased obesity. Study Links Genetic Risk for ADHD With Alzheimer's Disease A higher polygenic risk score for attention-deficit/hyperactivity disorder is also linked to cognitive decline and Alzheimer's disease, a new study in Molecular Psychiatry finds.